Comparative Pharmacology
Head-to-head clinical analysis: FUROXONE versus SATRIC.
Peer-Reviewed Evidence
Head-to-head clinical analysis: FUROXONE versus SATRIC.
FUROXONE vs SATRIC
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Furazolidone is a nitrofuran antimicrobial that inhibits bacterial monoamine oxidase and disrupts bacterial DNA synthesis by undergoing reduction by bacterial nitroreductases to reactive intermediates that cause DNA cross-linking and damage.
SATRIC is a combination of sulfathiazole, sulfacetamide, and sulfabenzamide, which are sulfonamide antibiotics. They competitively inhibit dihydropteroate synthase, blocking folate synthesis in susceptible bacteria.
100 mg orally four times daily
No standard dosing information available for SATRIC.
None Documented
None Documented
Terminal elimination half-life is approximately 1.5–2 hours; clinically, this supports dosing every 6 hours for sustained antibacterial effect.
3-5 hours in healthy adults; prolonged to 6-8 hours in renal impairment (CrCl < 30 mL/min)
Primarily renal (approximately 65%) as unchanged drug; biliary/fecal excretion accounts for about 35%.
Renal: 70% unchanged; fecal: 20%; biliary: 10%
Category C
Category C
Antibacterial/Antiprotozoal
Antiprotozoal, Antibiotic